Email Updates

You are here

AVAC in the News

  • The image on the slide deck was stark — a chart in the form of a towering blue mountain that showed the US facing a potential 2.2m deaths from coronavirus, were certain measures not taken. But the voice delivering the message was calm, almost soothing.

    April 6, 2020
    General
    Financial Times
  • In biomedical research, there is a “before HIV” era, and the world we live in now. Before HIV, most responses to public health crises were dictated top-down by government authorities and medical officials. Research was designed and conducted with little or no community input. Innovation was shunned, collaboration between research institutions avoided, and progress was slow.

    April 6, 2020
    General
    Science Speaks
  • Professor Gita Ramjee, a highly acclaimed scientist who dedicated her life to fighting and preventing HIV, has sadly died of coronavirus.

    April 2, 2020
    General
    Pink News
  • When the urgent phone call came last month, respected HIV researcher Deborah Birx was meeting with African officials and activists from around the world at a Johannesburg conference to help determine how US AIDS relief funding would be doled out.

    March 25, 2020
    General
    Los Angeles Times
  • There was good news and bad news in terms of HIV vaccine and therapeutics research, with several vaccine trials pushing forward even as one came to a premature halt.

    March 13, 2020
    Antibody Related Research, HIV Vaccine
    MedPage Today
  • Esnart Sikazindu’s stint with AVAC as a Fellow in 2020 is a step towards becoming an HIV prevention research advocate.

    March 6, 2020
    General
    Zambia Daily Mail
  • Before we begin the real story, a little bit of fiction. There is a cluster of houses of complex architecture. Unfortunately, they are in a neighbourhood teeming with the dangerous and cunning criminals. The houses are protec­ted by sophisticated security systems to fight off intruders. They have multiple layers of response mechanisms from the moment any intrusion is detected. They are engineered so that they can assess the threat perception and neutralize the intruder through a series of autonomous actions at different levels.

    February 22, 2020
    Outlook
  • HIV researchers in Kenya and around the world are regrouping to look for a way forward after a promising new vaccine failed a critical test.

    February 11, 2020
    Daily Nation
  • An HIV vaccine remains what South Africa and the world needs to prevent new HIV infections. This is in addition to a range of other HIV prevention tools that are available and in the pipeline. However, one of the HIV vaccine research studies, Uhambo (HVTN 702), has been stopped early because it was determined by an independent review body that it did not show a possibility to prevent HIV. This, for a moment, came as disappointing news; however, as South Africans we realise the search for a safe and effective HIV vaccine has to continue.

    February 6, 2020
    Daily Maverick
  • One of the biggest HIV vaccine trials in the world, the HVTN 702 study, was stopped late on Monday because the vaccine had not been proven effective in preventing HIV. This is according to the United States National Institute of Allergy and Infectious Diseases (NIAID), who are one of the funders of the clinical trial.

    February 4, 2020
    Health-E News

Pages